Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|June 3, 2008
Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II studyJean-Philippe Spano, Catherine Chodkiewicz, Joan Maurel, et al.
Annals of Hematology|April 22, 2020
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphomaAndrew Davies, Peter Trask, Judit Demeter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 8, 2023
Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical TrialsBellinda L King-Kallimanis, Melanie Calvert, David Cella, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2021
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II studyJoyce O'Shaughnessy, Susana Sousa, Josefina Cruz, et al.
Pediatric Blood & Cancer|August 11, 2020
Outcomes in children with hemophilia A with inhibitors: Results from a noninterventional studyJohannes Oldenburg, Midori Shima, Rebecca Kruse-Jarres, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 25, 2019
Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS)Johnny Mahlangu, Johannes Oldenburg, Michael U Callaghan, et al.
Research and Practice in Thrombosis and Haemostasis|September 29, 2022
Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3Michael U Callaghan, Elina Asikanius, Michaela Lehle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 15, 2018
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 StudyJohannes Oldenburg, Johnny N Mahlangu, Willem Bujan, et al.
Clinical Breast Cancer|June 3, 2025
Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II StudyJoyce O'Shaughnessy, Susana Sousa, Josefina Cruz, et al.
British Journal of Haematology|February 19, 2021
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN studyStephan Stilgenbauer, Francesc Bosch, Osman Ilhan, et al.
Pageof 3